1. Home
  2. FLGC vs AMS Comparison

FLGC vs AMS Comparison

Compare FLGC & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGC
  • AMS
  • Stock Information
  • Founded
  • FLGC 2019
  • AMS 1980
  • Country
  • FLGC United States
  • AMS United States
  • Employees
  • FLGC N/A
  • AMS N/A
  • Industry
  • FLGC Biotechnology: Pharmaceutical Preparations
  • AMS Medical Specialities
  • Sector
  • FLGC Health Care
  • AMS Health Care
  • Exchange
  • FLGC Nasdaq
  • AMS Nasdaq
  • Market Cap
  • FLGC 17.3M
  • AMS 19.3M
  • IPO Year
  • FLGC 2021
  • AMS N/A
  • Fundamental
  • Price
  • FLGC $0.54
  • AMS $2.75
  • Analyst Decision
  • FLGC Strong Buy
  • AMS
  • Analyst Count
  • FLGC 3
  • AMS 0
  • Target Price
  • FLGC $5.00
  • AMS N/A
  • AVG Volume (30 Days)
  • FLGC 175.1K
  • AMS 17.3K
  • Earning Date
  • FLGC 05-13-2025
  • AMS 04-04-2025
  • Dividend Yield
  • FLGC N/A
  • AMS N/A
  • EPS Growth
  • FLGC N/A
  • AMS 243.96
  • EPS
  • FLGC N/A
  • AMS 0.33
  • Revenue
  • FLGC $59,505,000.00
  • AMS $28,340,000.00
  • Revenue This Year
  • FLGC $4.28
  • AMS $13.15
  • Revenue Next Year
  • FLGC N/A
  • AMS N/A
  • P/E Ratio
  • FLGC N/A
  • AMS $8.21
  • Revenue Growth
  • FLGC N/A
  • AMS 32.90
  • 52 Week Low
  • FLGC $0.42
  • AMS $2.51
  • 52 Week High
  • FLGC $2.11
  • AMS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • FLGC 44.07
  • AMS 47.05
  • Support Level
  • FLGC $0.44
  • AMS $2.51
  • Resistance Level
  • FLGC $0.52
  • AMS $2.78
  • Average True Range (ATR)
  • FLGC 0.06
  • AMS 0.16
  • MACD
  • FLGC 0.01
  • AMS -0.00
  • Stochastic Oscillator
  • FLGC 51.75
  • AMS 48.98

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: